Business
Endonovo Therapeutics Hires David Clark as Vice President of Sales
Endonovo Therapeutics Hires David Clark as Vice President of Sales.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\nLos Angeles, May 03, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), today announced veteran sales leader David Clark joined as Endonovo’s Vice President of Sales. In his new position, Mr. Clark will lead the U.S. Sales Team, distributors and strategic partners through the next phase of growth. He'll be working with distributors, outside sales representatives and building an internal sales force to expand coverage and build high-value programs for customer support.\n Mr. Clark has 25 years of surgical device commercial experience with leading companies, including Medtronic and Baxter. Mr. Clark was most recently Executive Vice President of Sales for Biom’up, including the launch of surgical hemostat HEMOBLAST Bellows™. He built and led the U.S. Biom’up Sales Team, consisting of 200 plus in-direct sales representatives and direct commercial leaders. David holds a B.A. in Economics from Rutgers University. David Clark proclaimed, “I’m thrilled to join the Endonovo Therapeutics Team as there exists tremendous passion and excitement within the organization regarding our SofPulse® technology and being presented such a unique opportunity to so greatly impact patients’ lives” Alan Collier, Endonovo’s Chief Executive Officer, stated, “Endonovo continues to transform its business at a rapid pace. Over the past year the company has focused on clinical studies, building an expert management team and developing strategic partnerships. The focus now shifts to revenue growth and are fortunate to announce key hires leading our national rollout. The incredible talent we’ve assembled continues to make an impact and adding senior leadership only further underscores our commitment to serve. “I am excited David has decided to join us as his leadership style and personality perfectly complement our fast-paced, rapidly growing organization. Our entry into hospitals and medical care facilities is just the beginning of what we believe will be leading the charge against the opioid epidemic,” concluded Mr. Collier. About Endonovo Therapeutics Endonovo Therapeutics, Inc. is a commercial-stage developer of non-invasive wearable Electroceuticals™ therapeutic devices. The Company's current portfolio of commercial and clinical-stage wearable Electroc...